PsiOxus Therapeutics

Please note: The information displayed on this page might be outdated.
PsiOxus Therapeutics: Developer of cancer gene-therapies intended to focus on Immuno-oncology treatments for solid tumors. The company uses a proprietary intravenously administered T-SIGn virus platform and offers multiple clinical-stage assets for multiple solid cancer indications, enabling patients to get treatment against cancer.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe, United Kingdom
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Immuno-Oncology, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Private
Therapeutic Modalities
Gene editing
Website:
Address:
4-10, The Quadrant, Abingdon
Science Park
Abingdon, Oxfordshire OX14 3YS
United Kingdom

Company Participants at Boston Private Company Showcase

  • Melissa Epperly, CFO